Back
Primoris Services Vs. Avidity Biosciences Industry Stock Comparison
Buy
85
PRIM
Primoris Services
Last Price:
80.01
Seasonality Move:
6.05%
Sell
42
RNA
Avidity Biosciences
Last Price:
46.75
Seasonality Move:
39.98%
Buy
85
Primoris Services (PRIM)
is a Buy
Is Primoris Services a Buy, Sell or Hold?
- The current Primoris Services [PRIM] share price is $81.91. The Score for PRIM is 85, which is 70% above its historic median score of 50, and infers lower risk than normal.
- PRIM is currently trading in the 80-90% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk levels may be considerably lower than normal.
Sell
42
Avidity Biosciences (RNA)
is a Sell
Is Avidity Biosciences a Buy, Sell or Hold?
- The current Avidity Biosciences [RNA] share price is $47.13. The Score for RNA is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.
- RNA is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
PRIM Stock Price Chart
What is Primoris Services's stock price today?
-
The Primoris Services share price today is $81.91
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and PRIM is experiencing slight selling pressure.
RNA Stock Price Chart
What is Avidity Biosciences's stock price today?
-
The Avidity Biosciences share price today is $47.13
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RNA is experiencing slight selling pressure.
PRIM Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 5.29 | Buy |
| Relative Strength Index (14 RSI): | 87.47 | Buy |
| Chaikin Money Flow: | -226192 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (58.54 - 72.3) | Buy |
| Bollinger Bands (100): | (49.68 - 63.24) | Buy |
RNA Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.31 | Buy |
| Relative Strength Index (14 RSI): | 55.24 | Buy |
| Chaikin Money Flow: | -248351 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (43.93 - 47.71) | Buy |
| Bollinger Bands (100): | (41.2 - 46.58) | Buy |
PRIM Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 73.03 | Buy |
| 20-day SMA: | 66.57 | Buy |
| 50-day SMA: | 60.38 | Buy |
| 200-day SMA: | 50.49 | Buy |
| 8-day EMA: | 75 | Buy |
| 20-day EMA: | 68.65 | Buy |
| 50-day EMA: | 62.58 | Buy |
| 200-day EMA: | 51.57 | Buy |
RNA Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 45.33 | Buy |
| 20-day SMA: | 45.94 | Buy |
| 50-day SMA: | 44.62 | Buy |
| 200-day SMA: | 33.49 | Buy |
| 8-day EMA: | 46.11 | Buy |
| 20-day EMA: | 45.68 | Buy |
| 50-day EMA: | 44.8 | Buy |
| 200-day EMA: | 35.08 | Buy |
Primoris Services Earnings Growth & PRIM Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.32 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.71 per share, and an increase next year of $0.51 per share.
Avidity Biosciences Earnings Growth & RNA Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.10 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.05 per share, and a decrease next year of $0.36 per share.
Primoris Services Technical Analysis
| Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 29 | 30 | 31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Avidity Biosciences Technical Analysis
| Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 29 | 30 | 31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||